Dulcolax, Tylenol Rapid Release Claims Reviewed By NAD
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Division recommended Boehringer Ingelheim modify or discontinue certain claims for its Dulcolax (docusate sodium) stool softener in one of two OTC-related decisions handed out this week by the Council of Better Business Bureaus division